Events/1000 person y | ||||
---|---|---|---|---|
Outcomes | Oest + Prog | Placebo | Adjusted relative hazard (95% CI)‡ | NNH (CI) |
†Abbreviations defined in glossary; NNH and CI provided by author. | ||||
‡Relative hazard calculated using a Cox proportional hazards model with intention to treat analyses and adjusted for some demographic and baseline characteristics. | ||||
Venous thromboembolism | 5.9 | 2.8 | 2.06 (1.26 to 3.36) | 65 (35 to 187) |
Biliary tract surgery | 19.1 | 12.9 | 1.44 (1.10 to 1.90) | 32 (19 to 107) |
Any cancer | 19.7 | 16.5 | 1.19 (0.95 to 1.50) | Not significant |
Any fracture | 29.7 | 28.4 | 1.07 (0.89 to 1.29) | Not significant |
Total mortality | 30.6 | 27.8 | 1.08 (0.91 to 1.29) | Not significant |